Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Single Center Study to Evaluate the Efficacy of TIRZEPATIDE for the Treatment of Moderate to Severe Hidradenitis Suppurativa

NCT06301256 is registered in ClinicalTrials.gov with Florida Academic Centers Research and Education, LLC as lead sponsor.

NCT NCT06301256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06301256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Single Center Study to Evaluate the Efficacy of TIRZEPATIDE for the Treatment of Moderate to Severe Hidradenitis Suppurativa
Lead sponsor
Florida Academic Centers Research and Education, LLC
Phase
Not applicable
Overall status
Unknown status
Start date
March 11, 2024
Completion date
March 11, 2025
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hidradenitis suppurativa